There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Laboratory (LH), Pacira Pharmaceuticals (PCRX) and Icon (ICLR) with bullish sentiments.
Laboratory (LH)
Jefferies analyst Brian Tanquilut maintained a Buy rating on Laboratory on February 17 and set a price target of $275.00. The company’s shares closed last Wednesday at $255.03, close to its 52-week high of $259.29.
According to TipRanks.com, Tanquilut is a 4-star analyst with an average return of 7.7% and a 58.8% success rate. Tanquilut covers the Healthcare sector, focusing on stocks such as Acadia Healthcare, Tenet Healthcare, and Encompass Health.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Laboratory with a $269.50 average price target, implying a 5.7% upside from current levels. In a report issued on February 12, Citigroup also maintained a Buy rating on the stock with a $278.00 price target.
See today’s analyst top recommended stocks >>
Pacira Pharmaceuticals (PCRX)
In a report issued on March 23, David Steinberg from Jefferies maintained a Buy rating on Pacira Pharmaceuticals, with a price target of $85.00. The company’s shares closed last Wednesday at $70.09.
According to TipRanks.com, Steinberg is a 4-star analyst with an average return of 10.3% and a 51.9% success rate. Steinberg covers the Healthcare sector, focusing on stocks such as Amphastar Pharmaceuticals, Collegium Pharmaceutical, and Bausch Health Companies.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Pacira Pharmaceuticals with a $83.91 average price target, implying a 18.0% upside from current levels. In a report issued on March 25, Wedbush also reiterated a Buy rating on the stock with a $93.00 price target.
Icon (ICLR)
Jefferies analyst David Windley maintained a Buy rating on Icon on March 23 and set a price target of $240.00. The company’s shares closed last Wednesday at $196.37.
According to TipRanks.com, Windley is a top 100 analyst with an average return of 20.0% and a 75.5% success rate. Windley covers the Healthcare sector, focusing on stocks such as Molina Healthcare, Sotera Health, and UnitedHealth.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Icon with a $228.38 average price target, a 16.9% upside from current levels. In a report released today, Wells Fargo also upgraded the stock to Buy with a $235.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ICLR:
